secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2022-01-27T23:59:59+00:00
Accession:  0001193125-22-019977
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn terminates CEO Nader Pourhassan; CFO Migliarese named interim president
-------------------------------------------------------------------------------

- Board terminated CEO Nader Z. Pourhassan on Jan 24, 2022; he also resigned from the board.
- Antonio Migliarese, current CFO, elected interim president; a committee will search for a permanent CEO.
- Tanya Durkee Urbach elected Chairman of the Board; Scott Kelly remains CMO and director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000119312522019977/0001193125-22-019977-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000119312522019977/d276339d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-019977

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer